A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

NCT00963807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

Recurrent Non-Small Cell Lung Carcinoma
Stage IB Non-Small Cell Lung Carcinoma
Stage IIA Non-Small Cell Lung Carcinoma
Stage IIB Non-Small Cell Lung Carcinoma
Stage IIIA Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer

Interventions

DRUG: Cisplatin
PROCEDURE: CT
DRUG: Docetaxel
DRUG: FDG
DRUG: FLT
PROCEDURE: PET/CT
PROCEDURE: Surgery

Sponsor

National Cancer Institute (NCI)